Iovance Biotherapeutics Inc. buy Barclays PLC
Start price
14.04.25
/
50%
€3.00
Target price
14.04.26
€4.39
Performance (%)
-23.32%
Price
17:44
€2.30
Summary
This prediction is currently active. The price of Iovance Biotherapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -23.32%. This prediction currently runs until 14.04.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | -19.329% | -19.329% |
| iShares Core DAX® | -1.074% | 0.201% |
| iShares Nasdaq 100 | 3.110% | 5.822% |
| iShares Nikkei 225® | -2.154% | -0.860% |
| iShares S&P 500 | 2.634% | 5.633% |
Comments by Barclays_PLC for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Barclays PLC from $22.00 to $5.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by Barclays_PLC for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.63
12.05.25
12.05.25
€3.56
12.05.26
12.05.26
34.66%
17:44
17:44
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€15.05
29.02.24
29.02.24
€20.28
28.02.25
28.02.25
-73.24%
01.03.25
01.03.25